Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 3Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Lymphoid 1CNS 1

Conditions

Neoplasms 1Motor Activity 1Lung Neoplasms 1Hodgkin Disease 1Cardiovascular Diseases 1Brain Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Physical Conditioning, Human × Clear all
NCT04636255 2026-05-04

Physical Capacity in Hodgkin Lymphoma Survivors

University of Sao Paulo General Hospital

Phase NA Completed
40 enrolled
Lymphoid

Cardiovascular Diseases, Hodgkin Disease

NCT02749877 2019-03-19

Efficacy of Cognitive and Physical Trainings in Pediatric Cancer Survivors

Insel Gruppe AG, University Hospital Bern

Phase NA Completed
81 enrolled
CNS

Brain Neoplasms, Motor Activity, Neoplasms

NCT01748981 2019-02-12

FALC

Oslo University Hospital

Phase NA Completed
71 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡